James Carmichael, BSc, MBChB, MD, FRCP | Authors

September 02, 1997

An open-label, randomized phase III trial has been established to compare the efficacy and safety profile of tegafur and uracil (UFT) plus leucovorin with fluorouracil (5-FU) plus leucovorin as first-line chemotherapy for